Gulf Coast TX

Study Examines QoL, Depression After CAR-T for Hematologic Malignancy

Fort Bend Herald and Texas Coaster | Rosenberg

Apr 7, 2023

FRIDAY, April 7, 2023 (HealthDay News) -- For adults with hematologic malignancies receiving chimeric antigen receptor T-cell (CAR-T) therapy, quality of life (QoL) deteriorates an…

Read the full story at Fort Bend Herald and Texas Coaster | Rosenberg

Related places

Rosenberg

Study Examines QoL, Depression After CAR-T for Hematologic Malignancy

Related places

More from Gulf Coast

NFL roundup: Browns edge Ravens to grab share of AFC North lead

China's Q3 GDP growth set to pick up as exports power ahead

The Media Line: Iran Threatens Gulf Technology Firms, Announces Plans for Data Authority

The Media Line: Austrian Airlines Flight From Israel Diverts to Bulgaria After Bomb Threat

The Media Line: Documents Reveal Israel Encouraged Qatari Funding of Gaza Before October 7

Panthers Rally in Thrilling Homecoming Finish to Defeat Alcorn State

Australia's Challenger gets takeover bid from unit of Japan's Daiichi Life

The Media Line: Iran FM: Hormuz Could Open Friday if US Agrees to 7-Day Proposal